A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities
Clinical trial NCT07308106 · RECRUITING
Trial details
- NCT number
- NCT07308106
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-03
- Primary completion
- 2027-06-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.